AKBM: Q1 revenue up 13% to $57.3M, with record krill oil sales and improved EBITDA margin

About this update from Aker Biomarine Asa

Revenue grew 13% year-over-year to $57.3 million, driven by record krill oil sales and strong Human Health Ingredients performance. Adjusted EBITDA rose 34%, and the company completed a major refinancing, maintaining solid liquidity and leverage metrics.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Aker Biomarine Asa